SOLICITATION NOTICE
66 -- Rapid Sterility Detection System
- Notice Date
- 7/3/2007
- Notice Type
- Solicitation Notice
- NAICS
- 333319
— Other Commercial and Service Industry Machinery Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, MD, 20857-0001, UNITED STATES
- ZIP Code
- 00000
- Solicitation Number
- 1030997
- Response Due
- 7/18/2007
- Archive Date
- 8/2/2007
- Description
- The Food and Drug Administration intends to award a purchase order on a sole source non-competitive basis to Millipore Corporation, 290 Concord Rd., Billerica, MA 01821-7037. Item 0001, Catalog number: RMMXRP110, Microstar upgrade to Milliflex Rapid Package, Item 0002, MXRPLTVP1, Validation Protocol for Milliflex Rapid, Item 0003, MXRPBLRST, Milliflex Rapid Standard Reagent (France), Item 0004, MXRPCLKT1, Milliflex Rapid Cleaning Kit, Item 0005, RMHVMFX24, MFX For Microstar 0.45 um membrane, Item 0006, RSINSTL11, Rapid Micro Product Installation at Customer-Standard, Item 0007, RSVATVL11, Rapid Micro Travel Fees for Validation services, Item 0008, RSVALID12, Rapid Micro On-site Validation Services (Consultancy/PQ) on-site, Item 0009, RSSEMIN11, Rapid Micro Services- PMT seminar on-site, Item 0010, RSPMMXR12, Milliflex Rapid Premium Maintenance Contract on-site. This is an upgrade of an older Milliflex Rapid Sterility Detection System currently in use. The Milliflex Rapid Detection System is a microbal detection system which utilizes combination of 3 technologies (membrane filtration, ATP Bioluminescence and CCD) to detect and record the signals of viable organisms in culture. The combination of these technologies also enables the enumeration of viable micro-organisms on the surface of Durapore membrane filters. The ATP Biolumenscence assay allows for detection and enumeration of viable microorganisms via a light signal in a shortened period of time as compared to conventional sterility tests. This unit was originally selected because it is the only instrument currently available that utilizes the combination of technologies that permit detection and enumeration of viable contaminants in biological products. THIS IS NOT A REQUEST FOR QUOTES. However, sources may submit descriptive literature, fully documenting their capabilities, which will be considered by the agency. A determination to compete this procurement based on response(s) to this notice is solely within the discretion of the Government. The FDA intends to make an award immediately after the response date of this notice. The award will be made in accordance with FAR Part 13, Simplified Acquisition Procedures.
- Place of Performance
- Address: Bethesda, MD
- Zip Code: 20892
- Country: UNITED STATES
- Zip Code: 20892
- Record
- SN01333692-W 20070705/070703220420 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |